Benjamin L. Palleiko, CHIEF EXECUTIVE OFFICER at KalVista Pharmaceuticals, Inc. (KALV), sold 21,880 shares at $13.22 ($289K) on 2025-08-22, disclosed to the SEC on 2025-08-25.
Seasonal sale ($289k) by CHIEF EXECUTIVE OFFICER — this insider has traded KALV in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.22 | 10,940 | $145K | 50.0% |
| 2 | $13.22 | 10,940 | $145K | 50.0% |
| Total | $13.22 avg | 21,880 | $289K | 100% |
| Filing → |
| KALV | SELL | 2026-05-13 | $89K | — | Filing → |
| KALV | SELL | 2026-04-20 | $193K | — | Filing → |
| KALV | SELL | 2026-03-10 | $108K | — | Filing → |